Rimas Vincas Lukas

  • 514 Citations
20052023
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Dr. Lukas, sub-specializing in neuro-oncology, is interested in the care of patients with primary brain tumors and spinal cord tumors as well as central nervous system (CNS) metastases. Dr. Lukas's research centers on clinical trials in neuro-oncology. Additionally, he has a strong interest in medical education in the U.S. and internationally and conducts research in neuroscience medical education.

Training Experience

2003Internship, Cook County Hospital, Chicago
2006Residency, University of Chicago Hospitals
2008Fellowship, University of Chicago

Education/Academic qualification

MD, Rush University

… → 2002

Keywords

  • Brain Cancer / Nervous System Cancer
  • Medical Education
  • Neuro-Oncology
  • Spinal Cord Tumors
  • Spinal Oncology

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 16 Similar Profiles
Glioblastoma Medicine & Life Sciences
Neurology Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Glioma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Brain Neoplasms Medicine & Life Sciences
Central Nervous System Medicine & Life Sciences
Medical Students Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2018 2023

Research Output 2005 2019

Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study

Gadgeel, S. M., Lukas, R. V., Goldschmidt, J., Conkling, P., Park, K., Cortinovis, D., de Marinis, F., Rittmeyer, A., Patel, J. D., von Pawel, J., O'Hear, C., Lai, C., Hu, S., Ballinger, M., Sandler, A., Gandhi, M. & Fehrenbacher, L., Feb 1 2019, In : Lung Cancer. 128, p. 105-112 8 p.

Research output: Contribution to journalArticle

docetaxel
Non-Small Cell Lung Carcinoma
Neoplasm Metastasis
Brain
Nervous System

Commentary: preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma by Garg et al. (2017)

Zhai, L., Ladomersky, E., Lauing, K. L., Wu, M., Scholtens, D. M., Savoor, R., Zhang, B., Wu, J. D., Horbinski, C. M., Lukas, R. V., Binder, D. C. & Wainwright, D. A., Mar 4 2019, In : OncoImmunology. 8, 3, 1548242.

Research output: Contribution to journalComment/debate

Glioblastoma
Biomarkers
Computational Biology
Gene Expression
Open Access
Radiosurgery
Multicenter Studies
Melanoma
Phosphotransferases
Retrospective Studies

Comments

Lukas, R. V., Mar 1 2019, In : Clinical neurosurgery. 84, 3, 1 p.

Research output: Contribution to journalComment/debate

1 Citation (Scopus)

Imaging tryptophan uptake with positron emission tomography in glioblastoma patients treated with indoximod

Lukas, R. V., Juhász, C., Wainwright, D. A., James, C. D., Kennedy, E., Stupp, R. & Lesniak, M. S., Jan 15 2019, In : Journal of Neuro-Oncology. 141, 1, p. 111-120 10 p.

Research output: Contribution to journalArticle

Indoleamine-Pyrrole 2,3,-Dioxygenase
Glioblastoma
Tryptophan
Positron-Emission Tomography
temozolomide